Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements

Oncolytic viruses (OVs) have been gaining attention in the pharmaceutical industry as a novel immunotherapeutic and therapeutic adjuvant due to their ability to induce and boost antitumor immunity through multiple mechanisms. First, intrinsic mechanisms of OVs that enable exploitation of the host im...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Chae-Ok, Hong, JinWoo, Yoon, A-Rum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458317/
https://www.ncbi.nlm.nih.gov/pubmed/36091031
http://dx.doi.org/10.3389/fimmu.2022.953410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458317/
https://www.ncbi.nlm.nih.gov/pubmed/36091031
http://dx.doi.org/10.3389/fimmu.2022.953410

Ejemplares similares